What is Pregabalin and what drug class does it belong to?
Pregabalin is a synthetic analogue of gamma-aminobutyric acid (GABA), the brain’s primary inhibitory neurotransmitter. Despite its structural resemblance to GABA, Pregabalin does not bind directly to GABAA or GABAB receptors, nor does it alter GABA metabolism or reuptake.
Instead, Pregabalin belongs to a distinct pharmacological group called gabapentinoids (which also includes gabapentin). It binds selectively to the alpha-2-delta (α2δ) auxiliary subunit of voltage-gated calcium channels in central nerve terminals. By reducing calcium influx into hyper-excited neurons, Pregabalin reduces the release of excitatory neurotransmitters such as glutamate, noradrenaline, and substance P.
In simpler terms, Pregabalin acts like a volume control dial for hyper-sensitive or damaged nerves, dampening amplified pain and seizure signalling without shutting down normal brain function.
Key facts at a glance
| Feature | Details |
|---|---|
| Drug class | Gabapentinoid; anticonvulsant and neuropathic analgesic |
| UK Legal Status | Prescription-Only Medicine (POM); Class C Controlled Drug, Schedule 3 CD No Register |
| Licensed UK Indications | Peripheral and central neuropathic pain, generalised anxiety disorder (GAD), adjunctive therapy for focal seizures |
| Available Forms | Hard capsules (25mg to 300mg) and oral solution (20mg/ml) |
| Elimination Route | Almost entirely eliminated unchanged via the kidneys (renal clearance) |
| Prescription Validity | 28 days from date of signature under UK controlled drug regulations |
What is Pregabalin prescribed for in the UK?
Under guidance from the National Institute for Health and Care Excellence (NICE) and the British National Formulary (BNF), Pregabalin has three primary licensed indications in adults:
- Neuropathic (nerve) pain: Treating chronic pain resulting from damage to the peripheral or central nervous system. Common clinical scenarios include diabetic peripheral neuropathy, post-herpetic neuralgia (pain following shingles), spinal cord injury pain, and trigeminal neuralgia. Learn more in our Pregabalin for nerve pain guide.
- Generalised anxiety disorder (GAD): Prescribed for chronic, pervasive anxiety and excessive worry that has not responded adequately to initial psychological interventions or selective serotonin reuptake inhibitors (SSRIs). Read more in our Pregabalin for anxiety guide.
- Epilepsy (adjunctive therapy): Used in combination with other anti-epileptic medicines to treat focal (partial) seizures with or without secondary generalisation. Read more in our Pregabalin for epilepsy guide.
UK Controlled Drug status and prescribing rules
In April 2019, the UK Home Office reclassified Pregabalin as a Schedule 3 Controlled Drug under the Misuse of Drugs Regulations 2001 (and Class C under the Misuse of Drugs Act 1971). This decision followed advice from the Advisory Council on the Misuse of Drugs (ACMD) regarding rising rates of misuse, physical dependence, and fatal co-ingestions involving opioids.
What this means for UK patients:
- Prescription validity: Prescriptions are legally valid for a maximum of 28 days from the date signed.
- Quantity limits: Doctors are strongly recommended by NHS guidance not to prescribe more than 30 days’ supply on a single prescription.
- No repeat dispensing: Emergency supplies and electronic repeat dispensing schemes generally do not apply to Schedule 3 controlled drugs without strict clinical authorization.
- Proof of identity: Community pharmacists may request photo ID or signature confirmation upon collection.
Generic Pregabalin and UK brand names
Pregabalin was originally patented and marketed by Pfizer under the brand name Lyrica. Following patent expiry, generic versions manufactured by numerous pharmaceutical companies became available in the UK at significantly lower cost to the NHS.
Other brand-name products licensed in the UK include:
- Alzain
- Axalid
- Lecaent
All approved generic and branded Pregabalin capsules contain identical active chemical compounds and adhere to the same bioequivalence standards regulated by the Medicines and Healthcare products Regulatory Agency (MHRA). For full dosage forms and packaging details, see our UK brands, forms and strengths guide.
What Pregabalin is NOT
Because Pregabalin is used for pain and mood-related symptoms, it is frequently confused with other medication classes:
- It is not an opioid: Pregabalin does not act on mu-opioid receptors. It is not derived from the opium poppy and does not reverse with naloxone.
- It is not an NSAID: It has no anti-inflammatory properties and will not reduce swelling like ibuprofen, naproxen, or aspirin.
- It is not a simple painkiller: It does not treat tension headaches, toothaches, sprains, or mechanical joint wear.
- It is not an SSRI or SNRI: While prescribed for generalised anxiety disorder, it is not an antidepressant and does not inhibit serotonin reuptake.
- It is not a sleeping tablet: Although drowsiness is a very frequent side effect, Pregabalin is not licensed as a hypnotic or insomnia treatment.
Questions to ask your GP or pharmacist
- Which specific condition is Pregabalin being prescribed to treat in my case?
- How long should I take it before we review whether it is helping my symptoms?
- What starting dose am I taking, and will the dose need to be adjusted gradually?
- Are any of my current prescription medications, over-the-counter tablets, or supplements unsafe with Pregabalin?
- What should I do if I experience excessive drowsiness, balance difficulties, or swelling?